The European Union has approved new 'self-replicating' RNA vaccines that can spread to unvaccinated individuals without their consent. The medicine committee made a recommendation for the marketing of Kostaive, a vaccine intended to protect against COVID-19. Unlike traditional vaccines, which contain antigens to initiate an immune response, these RNA vaccines allow the vaccinated person's body to replicate the vaccination process.
Kostaive is delivered as a powder for injection and contains self-amplifying mRNA that encodes the spike protein of the SARS-CoV-2 virus. This means that the introduced mRNA can replicate itself within the body, leading to the production of more spike proteins, thereby generating an immune response against COVID-19. However, clinical trials have shown that 90% of participants experienced adverse effects, with some even requiring medical assistance after the first dose. Concerns have also been raised regarding potential bias in the findings since many authors of the study were employed by the producer, Arcturus Therapeutics.
Critics label this new technology as dangerous, suggesting it could act like a bioweapon that spreads beyond vaccinated individuals. Reports indicate that the vaccine may transmit through human interaction, potentially vaccinating those who do not consent to it. This raises apprehension about mandatory vaccinations without consent.
The new class of saRNA vaccines is designed to not only produce the spike protein but also the mechanism necessary for self-replication, making it fundamentally different from traditional vaccines. Some argue this technology could cause harmful and lasting health effects, with claims it may turn vaccinated individuals into sources of biological agents that could spread to others. There is also concern that this approach aims for widespread vaccination without addressing citizens’ hesitance regarding vaccines, reminiscent of past eugenics movements.
No comments:
Post a Comment